Titan Biotech Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 779371,
    "name": "Titan Biotech",
    "stock_name": "Titan Biotech",
    "full_name": "Titan Biotech Ltd",
    "name_url": "stocks-analysis/titan-biotech",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,036.70",
    "chg": 36.6,
    "chgp": "3.66%",
    "dir": 1,
    "prev_price": "1,000.10",
    "mcapval": "853.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524717,
    "symbol": "",
    "ind_name": "Specialty Chemicals",
    "ind_code": 11,
    "indexname": "",
    "isin": "INE150C01011",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "7.24 k",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/titan-biotech-779371-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Titan Biotech Sees Revision in Market Evaluation Amid Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/titan-biotech-upgraded-to-hold-by-marketsmojo-on-improving-fundamentals-3737220",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/TitanBiotech_mojoScore_3737220.png",
        "date": "2025-11-30 10:24:23",
        "description": "Titan Biotech's market evaluation has undergone a revision reflecting changes in its financial and technical outlook. The specialty chemicals company, classified as a microcap, has experienced a shift in assessment metrics driven by recent quarterly results and evolving market dynamics."
      },
      {
        "title": "Why is Titan Biotech falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-titan-biotech-fallingrising-3729773",
        "imagepath": "",
        "date": "2025-11-26 00:55:49",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Performance and Market Context</strong></p>\n<p>Titan Biotech’s recent price action stands out against broader market benchmarks. Over the past week, the stock has appreciated by 3.70%, while the Sensex marginally declined by 0.10%. This divergence highlights the stock’s relative strength in a generally flat market environment. Despite a one-month decline of 11.91%, the year-to-date returns remain robust at 40.20%, significantly outperforming the Sensex’s 8.25% gain over the same period. Over longer horizons, Titan Biotech has delivered exceptional returns, with a five-year gain exceeding 700%, dwarfing the benchmark’s 93% rise. These figures underscore the stock’s strong growth trajectory and investor confidence over time.</p>\n<p><strong>Intraday Volatility and Trading Range</st..."
      },
      {
        "title": "Titan Biotech Surges with Unprecedented Buying Interest, Eyes Multi-Day Upper Circuit",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/titan-biotech-surges-to-upper-circuit-on-unprecedented-buying-interest-3729102",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/TitanBiotech_only_buyers_3729102.png",
        "date": "2025-11-25 13:40:37",
        "description": "Titan Biotech has witnessed extraordinary buying momentum today, registering a 5.0% gain and hitting an intraday high of Rs 1,028.05. The stock’s order book reveals a striking absence of sellers, signalling a potential multi-day upper circuit scenario as demand continues to outpace supply in the specialty chemicals sector."
      },
      {
        "title": "Titan Biotech Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/titan-biotech-faces-intense-selling-pressure-hits-lower-circuit-amid-market-weakness-3728123",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/TitanBiotech_only_sellers_3728123.png",
        "date": "2025-11-25 09:41:17",
        "description": "Titan Biotech Ltd has encountered significant selling pressure in recent trading sessions, with the stock registering consecutive declines and exhibiting a rare scenario of exclusively sell orders. This distress selling signals heightened investor caution in the specialty chemicals sector as the stock underperforms key benchmarks."
      },
      {
        "title": "Titan Biotech Surges with Unprecedented Buying Interest, Eyeing Multi-Day Upper Circuit",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/titan-biotech-surges-to-upper-circuit-amid-unprecedented-buying-interest-3724147",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/TitanBiotech_only_buyers_3724147.png",
        "date": "2025-11-24 09:31:03",
        "description": "Titan Biotech Ltd witnessed extraordinary buying momentum on 24 Nov 2025, with the stock hitting the upper circuit limit and only buy orders queued, signalling a potential multi-day rally. This surge comes amid a backdrop of strong long-term performance and heightened market attention within the Specialty Chemicals sector."
      },
      {
        "title": "Titan Biotech Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/titan-biotech-faces-severe-selling-pressure-amid-lower-circuit-lockdown-3720759",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/TitanBiotech_only_sellers_3720759.png",
        "date": "2025-11-21 11:20:49",
        "description": "Titan Biotech Ltd has encountered significant selling pressure today, with the stock opening sharply lower and trading exclusively on sell orders. The company’s shares have recorded a fourth consecutive day of declines, signalling distress selling and a lack of buyer interest in the current market environment."
      },
      {
        "title": "Titan Biotech Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/titan-biotech-faces-severe-selling-pressure-hits-lower-circuit-amid-distress-signals-3717985",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/TitanBiotech_only_sellers_3717985.png",
        "date": "2025-11-20 11:21:21",
        "description": "Titan Biotech Ltd has encountered significant selling pressure on 20 Nov 2025, with the stock opening sharply lower and trading exclusively at its intraday low, signalling distress selling and a lack of buyer interest. This development comes amid a three-day consecutive decline, reflecting a challenging phase for the specialty chemicals company."
      },
      {
        "title": "Titan Biotech Faces Intense Selling Pressure Amid Lower Circuit Lock",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/titan-biotech-faces-lower-circuit-amid-extreme-selling-pressure-3715087",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/TitanBiotech_only_sellers_3715087.png",
        "date": "2025-11-19 10:31:23",
        "description": "Titan Biotech Ltd, a key player in the Specialty Chemicals sector, has encountered significant selling pressure today, with the stock hitting a lower circuit and exhibiting a queue dominated exclusively by sell orders. This unusual market behaviour signals distress selling and a lack of buyer interest, raising concerns about the stock’s immediate trading dynamics."
      },
      {
        "title": "Is Titan Biotech technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-titan-biotech-technically-bullish-or-bearish-3713924",
        "imagepath": "",
        "date": "2025-11-19 08:16:03",
        "description": "As of 18 November 2025, the technical trend for Titan Biotech has changed from bullish to mildly bullish. The weekly MACD remains bullish, supporting a positive outlook, while the monthly MACD is also bullish, indicating strength over a longer time frame. The Bollinger Bands are showing a mildly bullish stance on both weekly and monthly charts, which aligns with the daily moving averages that are also mildly bullish. However, the KST indicates a mixed signal with a bullish weekly reading but a mildly bearish monthly reading. The Dow Theory shows a mildly bearish stance on the weekly chart, suggesting some caution. Overall, the current technical stance is mildly bullish, driven primarily by the bullish MACD and Bollinger Bands, despite some mixed signals from KST and Dow Theory...."
      }
    ],
    "total": 364,
    "sid": "779371",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/titan-biotech-779371"
  },
  "announcements": [
    {
      "caption": "Newspaper Advertisement Pertaining To Transfer Of Physical Shares Under Special Window",
      "datetime": "30-Jan-2026",
      "details": "Newspaper Advertisement submission for inviting claims or objection for transfer of physical Shares under Special Window",
      "source": "BSE"
    },
    {
      "caption": "Re-Lodgement Of Transfer Requests Of Physical Shares",
      "datetime": "15-Jan-2026",
      "details": "Please find attached herewith report for the month of December 2025 pertaining to re-lodgements of transfer of Physical Shares",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "07-Jan-2026",
      "details": "Certificate under Reg. 74(5) of SEBI (DP) Regulations 2018 for quarter ended 31st December 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Titan Biotech Ltd has declared <strong>20%</strong> dividend, ex-date: 19 Sep 25",
          "dt": "2025-09-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Titan Biotech Sees Revision in Market Evaluation Amid Mixed Financial Signals

2025-11-30 10:24:23

Titan Biotech's market evaluation has undergone a revision reflecting changes in its financial and technical outlook. The specialty chemicals company, classified as a microcap, has experienced a shift in assessment metrics driven by recent quarterly results and evolving market dynamics.

Why is Titan Biotech falling/rising?

2025-11-26 00:55:49

Recent Price Performance and Market Context Titan Biotech’s recent price action stands out against broader market benchmarks. Over the past week, the stock has appreciated by 3.70%, while the Sensex marginally declined by 0.10%. This divergence highlights the stock’s relative strength in a generally flat market environment. Despite a one-month decline of 11.91%, the year-to-date returns remain robust at 40.20%, significantly outperforming the Sensex’s 8.25% gain over the same period. Over longer horizons, Titan Biotech has delivered exceptional returns, with a five-year gain exceeding 700%, dwarfing the benchmark’s 93% rise. These figures underscore the stock’s strong growth trajectory and investor confidence over time. Intraday Volatility and Trading Range</st...

Titan Biotech Surges with Unprecedented Buying Interest, Eyes Multi-Day Upper Circuit

2025-11-25 13:40:37

Titan Biotech has witnessed extraordinary buying momentum today, registering a 5.0% gain and hitting an intraday high of Rs 1,028.05. The stock’s order book reveals a striking absence of sellers, signalling a potential multi-day upper circuit scenario as demand continues to outpace supply in the specialty chemicals sector.

Titan Biotech Faces Intense Selling Pressure Amid Consecutive Losses

2025-11-25 09:41:17

Titan Biotech Ltd has encountered significant selling pressure in recent trading sessions, with the stock registering consecutive declines and exhibiting a rare scenario of exclusively sell orders. This distress selling signals heightened investor caution in the specialty chemicals sector as the stock underperforms key benchmarks.

Titan Biotech Surges with Unprecedented Buying Interest, Eyeing Multi-Day Upper Circuit

2025-11-24 09:31:03

Titan Biotech Ltd witnessed extraordinary buying momentum on 24 Nov 2025, with the stock hitting the upper circuit limit and only buy orders queued, signalling a potential multi-day rally. This surge comes amid a backdrop of strong long-term performance and heightened market attention within the Specialty Chemicals sector.

Titan Biotech Faces Intense Selling Pressure Amid Consecutive Losses

2025-11-21 11:20:49

Titan Biotech Ltd has encountered significant selling pressure today, with the stock opening sharply lower and trading exclusively on sell orders. The company’s shares have recorded a fourth consecutive day of declines, signalling distress selling and a lack of buyer interest in the current market environment.

Titan Biotech Faces Intense Selling Pressure Amid Consecutive Losses

2025-11-20 11:21:21

Titan Biotech Ltd has encountered significant selling pressure on 20 Nov 2025, with the stock opening sharply lower and trading exclusively at its intraday low, signalling distress selling and a lack of buyer interest. This development comes amid a three-day consecutive decline, reflecting a challenging phase for the specialty chemicals company.

Titan Biotech Faces Intense Selling Pressure Amid Lower Circuit Lock

2025-11-19 10:31:23

Titan Biotech Ltd, a key player in the Specialty Chemicals sector, has encountered significant selling pressure today, with the stock hitting a lower circuit and exhibiting a queue dominated exclusively by sell orders. This unusual market behaviour signals distress selling and a lack of buyer interest, raising concerns about the stock’s immediate trading dynamics.

Is Titan Biotech technically bullish or bearish?

2025-11-19 08:16:03

As of 18 November 2025, the technical trend for Titan Biotech has changed from bullish to mildly bullish. The weekly MACD remains bullish, supporting a positive outlook, while the monthly MACD is also bullish, indicating strength over a longer time frame. The Bollinger Bands are showing a mildly bullish stance on both weekly and monthly charts, which aligns with the daily moving averages that are also mildly bullish. However, the KST indicates a mixed signal with a bullish weekly reading but a mildly bearish monthly reading. The Dow Theory shows a mildly bearish stance on the weekly chart, suggesting some caution. Overall, the current technical stance is mildly bullish, driven primarily by the bullish MACD and Bollinger Bands, despite some mixed signals from KST and Dow Theory....

View All News